《半日总结》恒指升347点 友邦续强 药股发力
港股半日急升逾300点，重越牛熊线(27,381点)。恒指今早高开199点，友邦(01299.HK)及中资金融股带领下，一度弹高398点曾高见27,499点，半日仍涨347点或1.3%，收27,448；国指扬156点或1.5%，报10,779。大市成交录得475.34亿元。沪、深港通南下交易半日净流入金额分别为3.36亿及5.54亿元人民币。
成交最活跃五大股份，腾讯(00700.HK)今早升逾1%报325.4元；盈富(02800.HK)扬逾1%报27.65元；友邦重上80元关，续涨逾2%报81.4元；中国平安(02318.HK)及建行(00939.HK)分别升1.8%及1.4%，报93.4元及6.45元。
汇控(00005.HK)升0.6%报59.95元；港交所(00388.HK)将於本周三(6日)放榜，今早微升0.5%报248.6元；中移动(00941.HK)稳升0.5%报64.6元；中国铁塔(00788.HK)逆市跌0.6%报1.77元；中手游(00302.HK)抽升逾18%报4.12元，接近4.13元上市新高。
医药股受捧，石药(01093.HK)获瑞信重申「跑赢大市」，刺激股价半日升4.4%报20.7元，为最强蓝筹；中生制药(01177.HK)亦有3.4%进帐报12.12元；同业复星医药(02196.HK)、国药(01099.HK)及中国中药(00570.HK)均上升逾2%。
手机股方面，舜宇(02382.HK)开市初段曾升3.6%至134元，惟升幅显着收窄，半日扬逾1%报130.9元；瑞声(02018.HK)将於本周五(8日)公布季绩，今早逆市跌0.5%报51.25元。
个别股份方面，中国置业投资(00736.HK)炒高1.3倍至0.046元，成交涉677.1万元，为最大升幅个股；华地国际(01700.HK)大股东每股2.3元提私有化，今早复牌後急涨逾50%报2.12元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
